For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...

Data from 32 studies concluded that the impact of exercise is modest in terms of meaningful weight loss. Caloric restriction ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

CagriSema vs placebo was associated with significant weight loss among adults with overweight or obesity with or without type ...

We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

We're going to be taking a look at how Kathy Bates managed to drop 100 pounds with and without the use of Ozempic.

Lifestyle therapy may not be enough to improve outcomes for patients with HF and obesity, but careful risk evaluation and ...

Obesity, defined by a BMI over 30, significantly impacts dermatological health due to excess adipose tissue's endocrine activity, leading to chronic inflammation and impaired immunity. This increases ...

If your weight loss journey involves a specific diet plan besides calorie-cutting — such as a Mediterranean diet, plant-based diet, or keto diet — you can choose to include artificial ...

An experimental muscle-preserving drug called bimagrumab helped people taking semaglutide (Ozempic/Wegovy) keep their muscle ...